MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01900nam a2200277 a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
vtls000043037 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
KUKTEM |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20251117145148.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
090902t2009 enka b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780470092545 (hbk) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0470092548 (hbk) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780470092552 (pbk) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0470092556 (pbk) |
| 039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE] |
|---|
| Level of rules in bibliographic description |
201107132032 |
| Level of effort used to assign nonsubject heading access points |
VLOAD |
| Level of effort used to assign subject headings |
201008190925 |
| Level of effort used to assign classification |
jamie |
| -- |
200909021419 |
| -- |
farina |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
|---|
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
RC271.C5 A57 2009 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Airley, Rachel. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Cancer chemotherapy / |
| Statement of responsibility, etc. |
Rachel Airley |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Chichester, UK ; |
| -- |
Hoboken, NJ : |
| Name of publisher, distributor, etc. |
Wiley-Blackwell, |
| Date of publication, distribution, etc. |
2009 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
x, 341 p., [8] p. of plates : |
| Other physical details |
ill. (some col.) ; |
| Dimensions |
25 cm. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Cancer epidemiology -- Histopathology of cancer -- Carcinogenesis, malignant transformation, and progression -- Molecular biology of cancer : oncogenes and tumour suppressor genes -- Tumour metastasis : a convergence of many theories -- Health professionals in the treatment of cancer -- Principles of cancer chemotherapy -- Classic anticancer agents -- The philosophy of cancer research -- Novel anticancer agents -- Clinical trials -- Tumour hypoxia -- Antiangiogenic and antivascular agents -- Tyrosine kinase inhibitors -- Ras inhibitors -- Inhibitors of the Akt/PKB pathway -- Targeting stress proteins: HSP90 inhibitors -- The proteasome -- Checkpoint protein kinases as novel targets : mammalian target of rapamycin (mTOR) -- Telomerase -- Histone deacetylase : an epigenetic drug target -- Pharmaceutical problems in cancer chemotherapy -- Oncology pharmacy at home and abroad -- Practice exam questions |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Cancer |
| General subdivision |
Chemotherapy |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Neoplasms |
| General subdivision |
drug therapy |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Antineoplastic Agents |
| General subdivision |
therapeutic use |